MDT perspectives on how GLP-1 RAs can reduce stroke risk

17/11/2022 14 min Episodio 191
MDT perspectives on how GLP-1 RAs can reduce stroke risk

Listen "MDT perspectives on how GLP-1 RAs can reduce stroke risk"

Episode Synopsis

touchMDT for touchNEUROLOGY
Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D
The multidisciplinary team
Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece

This touchPODCAST is for HCPs only.  
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d/ 

More episodes of the podcast touchPODCAST